TIM
MRNA icon

Thompson Investment Management’s Moderna MRNA Stock Holding History

Thompson Investment Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2
Closed -$134 – 520
2024
Q3 		$134 Hold
2
– – ﹤0.01% 489
2024
Q2 		$237 Sell
2
-2
-50% -$253 ﹤0.01% 484
2024
Q1 		$409 Buy
4
+2
+100% +$202 ﹤0.01% 493
2023
Q4 		$199 Hold
2
– – ﹤0.01% 411
2023
Q3 		$207 Hold
2
– – ﹤0.01% 395
2023
Q2 		$243 Buy
+2
New +$267 ﹤0.01% 399

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Thompson Investment Management's MRNA Position: Q4 2024 in Review

Thompson Investment Management sold out of Moderna (MRNA) in Q4 2024, closing a stake of 2 shares — an estimated $134 sold.

Thompson Investment Management first reported a position in MRNA in Q2 2023 and held it in 6 quarters. The position peaked at $409 in Q1 2024. 745 funds tracked by Wall St. Rank hold MRNA as of Q4 2024.

  • Thompson Investment Management reported no remaining Moderna position as of Q4 2024 after selling out during the quarter.
  • Thompson Investment Management sold 2 Moderna shares in Q4 2024, an estimated $134.
  • Thompson Investment Management first reported a position in Moderna in Q2 2023 and held it in 6 quarters.
  • Thompson Investment Management's Moderna position peaked at $409 in Q1 2024.
  • 745 funds tracked by Wall St. Rank held Moderna as of Q4 2024.

Based on Thompson Investment Management's 13F filing for Q4 2024, filed 28 Jan 2025.